Research programme: fluoroquinolones - Kyorin
Alternative Names: AM-1939; AM-1954; Compound 21Latest Information Update: 04 Nov 2017
At a glance
- Originator Kyorin Pharmaceutical
- Class Fluoroquinolones
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Bacterial-infections in Japan (PO)
- 09 Jul 2008 Preclinical development is ongoing
- 03 Oct 2007 Preclinical trials in Bacterial infections in Japan (unspecified route)